RETRIeVE: ReversE TranscRiptase Inhibitor hiV Practice

Observational Study on Anti-Tat Immune Response in HIV-1-infected HAART-treated Adult Subjects

NCT01024556 ·Status: COMPLETED

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral HRS5685 in Healthy Subjects

NCT05328583 ·Status: UNKNOWN ·Phase: PHASE1

Immunological and Viral Response to Antiretrovirals in HIV Patients With CD4 Cell Count Below 100

NCT00385957 ·Status: COMPLETED ·Phase: PHASE4

Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.

NCT00386659 ·Status: TERMINATED ·Phase: PHASE4

Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease

NCT00775606 ·Status: TERMINATED ·Phase: PHASE4

Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment

NCT01363011 ·Status: COMPLETED ·Phase: PHASE3

Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria

NCT01044771 ·Status: COMPLETED ·Phase: NA

Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals

NCT06507059 ·Status: RECRUITING ·Phase: PHASE3

Immuno-Virological Efficacy of Combination With Trizivir +Tenofovir in Multiresistant HIV Patients

NCT00356616 ·Status: TERMINATED ·Phase: PHASE4

Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load

NCT00454337 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial to Evaluate the Effects of Letermovir Prophylaxis on T-cell Immune Activation in Participants With Treated HIV-1 Infection

NCT06626555 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

CAbotégravir LENacapavir DUal Long Acting

NCT06657885 ·Status: WITHDRAWN ·Phase: PHASE2

The Tolerability of, and Adherence to, Dolutegravir With Co-formulated Tenofovir-emtricitabine for HIV Non-occupational Post-exposure Prophylaxis

NCT02211690 ·Status: COMPLETED ·Phase: PHASE4

Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults

NCT00608569 ·Status: COMPLETED ·Phase: NA

Emtricitabine/Tenofovir Alafenamide as Salvage ART

NCT02556333 ·Status: TERMINATED ·Phase: PHASE2

Study of the Effectiveness of Passive Immunotherapy in HIV-Infected Patients Who Are in Virologic Failure

NCT00353327 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3

Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study)

NCT00615563 ·Status: COMPLETED

Intermittent Versus Continuous Medication in the Treatment of HIV

NCT00001967 ·Status: COMPLETED ·Phase: PHASE4

A Pilot,Raltegravir Versus NRTIs as a Backbone Switched From a Stable Boosted PI Regimen

NCT00749580 ·Status: COMPLETED ·Phase: NA

Study of KP-1461 for the Treatment of HIV Positive Patients Who Have Failed Multiple HAART Regimens

NCT00129194 ·Status: COMPLETED ·Phase: PHASE1

Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects

NCT00966329 ·Status: COMPLETED ·Phase: PHASE4

Raltegravir Therapy for Women With HIV and Fat Accumulation

NCT00656175 ·Status: COMPLETED ·Phase: PHASE2

Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load

NCT00515827 ·Status: COMPLETED ·Phase: PHASE2

Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected Patients

NCT00551655 ·Status: COMPLETED

Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance

NCT04150068 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3